Clinical Studies

MITRO is unique in that it has established a network of radiopharmaceutical tracer production, and imaging centers for PET acquisition and image analysis utilizing the most advanced neuroimaging tracer compounds available to be used in China and Asia.

Clinical Trials of Novel Radiopharmaceuticals

MITRO is a CRO company focusing on the clinical trials of novel radiopharmaceuticals. It can provide one-stop services such as clinical operation, MA, RA, PV, quality management and medical imaging, etc.

Medical Affairs

MITRO medical team have a PhD or Master's degree or above in clinical medicine, pharmacy and other related majors.

Biological Sample Analysis

MITRO Clinical has completed the biological sample analysis for a number of pharmaceutical clinical trials, including18F，177Lu，90Y, etc.

Clinical Development Strategy

Radiopharmaceutical studies are different from general medicines, which requires researchers to have a full understanding of radiopharmaceuticals and rich experience in radiopharmaceutical projects.

FIH Center

The FIH (First in Human, FIH) Center established by MITRO in New Haven, USA, was officially launched in October 2024. The center is committed to providing advanced imaging services to global sponsors.

XingImaging

XingImaging is a neuroimaging services company specializing in the efficient application of scintigraphic biomarkers in drug development and clinical research for neurodegenerative and neuropsychiatric disorders.

MITRO Biotech Co., Ltd.

Telephone: +86-25-52118501

E-mail: info@mi-tro.com

Address: Building 8, Qiande Road, Jiangning Science Park, Nanjing, Jiangsu Province, China

MITRO Official Account

Business License